Healthcare Training Institute
- Quality Education since 1979
Psychologist,
Social Worker, Counselor, & MFT!!

Section
34
Atypical
Antidepressant Medications
Question 34 found at the
bottom of this page
Test
| Table of Contents
Selective serotonin reuptake inhibitors (SSRIs) are medications
that increase the amount of the neurochemical serotonin in the
brain. Brain serotonin levels are low in depression. The SSRIs
work by selectively inhibiting or blocking serotonin reuptake
in the brain. This block occurs at the synapse, the place where
brain cells are connected to each other. Serotonin is one of the
chemicals in the brain that carries messages across these connections
from one neuron to another. The SSRIs work by keeping the serotonin
present in high concentrations in the synapses. These drugs do
this by preventing the reuptake of serotonin back into the sending
nerve cell. The reuptake of serotonin is responsible for turning
off the production of new serotonin. Therefore, the serotonin
message keeps on coming through. This, in turn, helps arouse or
activate cells that have been deactivated by depression, and relieves
the depressed person’s symptoms. In the United States, SSRIs
have been used successfully for over a decade to treat depression.
Examples
of SSRIs include fluoxetine (Prozac), paroxetine (Paxil),
sertraline (Zoloft), citalopram (Celexa), and fluvoxamine (Luvox).
SSRIs are generally well tolerated and side effects are usually
mild. The most common side effects are nausea, diarrhea, agitation,
insomnia, and headache. However, these side effects generally
go away within the first month of SSRI use. Some patients experience
sexual side effects, such as decreased sexual desire (decreased
libido), delayed orgasm, or an inability to have an orgasm. Some
patients experience tremors with SSRIs. The so-called serotonergic
(meaning caused by serotonin) syndrome is a serious neurologic
condition associated with the use of SSRIs. It is characterized
by high fevers, seizures, and heart rhythm disturbances. This
condition is very rare and has been reported only in very ill
psychiatric patients taking multiple psychiatric medications.
Dual
Action Antidepressants: The biochemical reality is that
all classes of medications that treat depression (MAOIs, SSRIs,
TCAs, and atypical antidepressants) have some effect on both norepinephrine
and serotonin, as well as on other neurotransmitters. However,
the various medications affect the different neurotransmitters
in varying degrees.
Some of the newer antidepressant drugs, however, appear to have
particularly robust effects on both the norepinephrine and serotonin
systems. These drugs seem to be very promising, especially for
the more severe and chronic cases of depression. (Psychiatrists,
rather than family practitioners, see such cases most frequently.)
Venlafaxine (Effexor) is one of these dual action compounds. It
is a serotonin reuptake inhibitor that, at lower doses, shares
many of the safety and low side effect characteristics of the
SSRIs. At higher doses, this drug appears to block the reuptake
of norepinephrine. Thus, venlafaxine can be considered an SNRI,
a serotonin and norepinephrine reuptake inhibitor.
Another newer antidepressant, mirtazapine (Remeron), is a tetracyclic
compound (four-ring chemical structure). It works at somewhat
different biochemical sites and in different ways than the other
drugs. It affects serotonin, but at a post-synaptic site (after
the connection between nerve cells.) It also increases histamine
levels, which can cause drowsiness. For this reason, mirtazapine
is given at bedtime and is often prescribed for people who have
trouble falling asleep. Like venlafaxine, it also works by increasing
levels in the norepinephrine system. Other than causing sedation,
this medication has side effects that are similar to those of
the SSRIs, but to a lesser degree in many cases.
Atypical
antidepressants are so named because they work in a variety of
ways. Thus, atypical antidepressants are not SSRIs, but they act
similarly. More specifically, they increase the level of certain
neurochemicals in the brain synapses. Examples of atypical antidepressants
include nefazodone(Serzone), trazodone (Desyrel), venlafaxine
(Effexor), and bupropion (Wellbutrin). Lithium (Eskalith, Lithobid),
valproate (Depakene, Depakote), carbamazepine (Epitol, Tegretol),
neurontin (Gabapentin), and lamictal (Lamotrigine) are mood stabilizers
and anticonvulsants. They have been used to treat bipolar depression.
Certain antipsychotic medications, such as ziprasidone (Geodon),
risperidone (Risperdal), and quetiapine (Seroquel), have sometimes
also been used to treat bipolar depression, usually in combination
with other antidepressants and/or the mood stabilizers.
“Personal
Reflection” Journaling Activity #14
The preceding section was about Medications for Depression. Write
three case study examples regarding how you might use the content
of this section of the Manual or the “Positive Reinforcement”
section of the audio tape in your practice.
QUESTION
34:
What medication is a serotonin reuptake inhibitor that, at lower
doses, shares many of the safety and low side effect characteristics
of the SSRIs; and at higher doses, this drug appears to block
the reuptake of norepinephrine?
Test
for this course
Forward
to Section 35
Back to Section 33
Table of Contents
Top